Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Department of Biology of Reproduction
Paris, 75014, France
NCT Number: NCT02144558
Spinal cord injured (SCI) men, para or tetraplegic, most often have an infertility, caused among others by a deficiency of sperm quality particularly motility and vitality. Several mechanisms have been proposed: low frequency of ejaculation, recurrent urinary tract and seminal infections, presence of an inflammatory syndrome (IS) and an oxidative stress (OS). However, no French study of sperm quality has been conducted in this population that could identify aggravating factors of sperm quality and a way to prevent them.
Hypothesis: Sperm parameters decrease rapidly following spinal cord injury and next stabilise. However, unidentified yet risk factors could influence long-term evolution of sperm parameters.
The objective is to study the evolution of sperm parameters during 18 months taking into account bladder management, recurrent urinary tract and bladder infections, IS and OS. The evaluation of these parameters and their consequences will be indicative to determine one or more risk factors of sperm degradation and determine a strategy for long term support to avoid the use of ART either by sperm cryopreservation and/or by preventing risk factors
Looking for future studies?
Notify Me18 year–60 year
Male
Interventional
Not applicable
Paris, 75014, France
SCI men are mostly young adults who have not completed their parental project. Infertility has many causes: erectile dysfunction, anejaculation (85% of SCI ) and altered sperm parameters. Penile vibratory stimulation allows 75 % of the sperm collection. If sperm quality is sufficient, intravaginal insemination of their partner at home is possible. The use of AMP remains common, which is damaging to men non sterile priori. In SCI, sperm concentration remains satisfactory but mobility and vitality are impaired. The installation of this irreversible degradation likely occurs very quickly after the trauma. The possible deterioration of sperm parameters with time is not known. The following pathophysiological mechanisms have been proposed: i) increased scrotal temperature, ii) decreased ejaculatory frequency, iii) recurrent urinary tract and seminal infections, iv ) inflammation and oxidative stress in the semen. Patients, and even rehabilitation doctors often submit an application for preventive sperm conservation but in the absence of prospective longitudinal data on the evolution of sperm quality of SCI men over the time and identified risk factors of degradation, the indication and timing of preventive cryopreservation remain to be defined.
Hypothesis: The sperm parameters, mobility and vitality, in SCI patients with or without penile vibratory stimulation (PVS), decrease in the immediate aftermath of trauma and next stabilize out the occurrence of intercurrent medical events or symptomatic urogenital infections. However, unidentified yet risk factors could influence long-term evolution of these sperm parameters.
Main objective: Monitoring the evolution of sperm parameters for 18 months: concentration, mobility, vitality, sperm morphology, inflammatory syndrome and oxidative stress on 4 ejaculates collected by masturbation or SVP at 6-month intervals.
Secondary objectives: In case of impaired sperm quality, identify risk factors for this change.
SCI men will have 4 medical visits associated to sperm retrieval spaced to 6 months during 18 months. At each visit medical and reproductive informations will be collected.
Knowledge of the evolution of sperm parameters and risk factors of its degradation over time must answer with the criteria of "evidence based medicine" the request of sperm cryopreservation frequently expressed by SCI patients. This study should lead to the optimization of the management of infertility in patients with spinal cord injuries and giving directions for research aiming to prevent the degradation of sperm parameters. Finally, this study should provide the rationale for future research on clinical risk factors and / or biological degradation of sperm and biological markers of risk of degradation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
penile vibratory stimulation (PVS) or masturbation
Time frame: 18 month
Sperm viability is a stable criteria of evaluation and it has a good repeatability in our lab.
Sperm viability is measured on fresh sperm 30 minutes after ejaculation using eosine nigrosine coloration. This measure is repeated on each of the four ejaculates obtained at 6 months apart.
Time frame: 18 months
Sperm concentration, mobility and morphology
Time frame: 6 month
Measure of inflammation
Time frame: 18 months
Sperm DNA integrity, measures oxidative stress
Time frame: 18 months
Oxydative stress
Time frame: 18 months
Secretion of seminal tract
Time frame: 18 months
Bacteriological analysis of sperm and urine
Time frame: 18 months
Time frame: 0 months
Type and level of the lesion
Time frame: 18 months
Time frame: 18 months
Time frame: 6 months
Sperm viability is a stable criteria of evaluation and it has a good repeatability in our lab.
Sperm viability is measured on fresh sperm 30 minutes after ejaculation using eosine nigrosine coloration. This measure is repeated on each of the four ejaculates obtained at 6 months apart.
Time frame: 12 months
Sperm viability is a stable criteria of evaluation and it has a good repeatability in our lab.
Sperm viability is measured on fresh sperm 30 minutes after ejaculation using eosine nigrosine coloration. This measure is repeated on each of the four ejaculates obtained at 6 months apart.
Time frame: 0 months
Sperm viability is a stable criteria of evaluation and it has a good repeatability in our lab.
Sperm viability is measured on fresh sperm 30 minutes after ejaculation using eosine nigrosine coloration. This measure is repeated on each of the four ejaculates obtained at 6 months apart.
Time frame: 0 month
Measure of inflammation
Time frame: 12 month
Measure of inflammation
Time frame: 18 month
Measure of inflammation
Time frame: 0 months
Sperm concentration, mobility and morphology
Time frame: 6 months
Sperm concentration, mobility and morphology
Time frame: 12 months
Sperm concentration, mobility and morphology
Time frame: 0 month
Sperm DNA integrity, measures oxidative stress
Time frame: 6 months
Sperm DNA integrity, measures oxidative stress
Time frame: 12 months
Sperm DNA integrity, measures oxidative stress
Time frame: 0 months
Oxydative stress
Time frame: 6 months
Oxydative stress
Time frame: 0 months
Secretion of seminal tract
Time frame: 6 months
Secretion of seminal tract
Time frame: 12 months
Secretion of seminal tract
Time frame: 0 months
Bacteriological analysis of sperm and urine
Time frame: 6 months
Bacteriological analysis of sperm and urine
Time frame: 12 months
Bacteriological analysis of sperm and urine
Time frame: 0 months
Time frame: 6 months
Time frame: 12 months
Time frame: 0 month
Time frame: 6 months
Time frame: 12 months
Time frame: 0 month
Time frame: 6 months
Time frame: 12 months
Assistance Publique - Hôpitaux de Paris
Other
Evolution of Sperm Parameters and Study of Risk Factors of Impairment of Sperm Quality in Spinal Cord Injuries. Longitudinal Prospective Study.
Acronym: FertiSCI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05589402
Bone Diseases, Brain Diseases
Harlingen, Texas, United States
View Trial DetailsNCT07738913
Central Nervous System Diseases, Nervous System Diseases
Kaohsiung City, Taiwan
View Trial DetailsNCT07293949
Arthritis, Central Nervous System Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07725081
Attitudes, Behavior
Afyonkarahisar, Turkey (Türkiye)
View Trial Details